S. Pålhagen

发表

Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.

C. Halldin, L. Farde, J. Matthews, 2006, Brain : a journal of neurology.

Interim analysis of long‐term intraduodenal levodopa infusion in advanced Parkinson disease

D. Nyholm, A. Johansson, H. Widner, 2012, Acta neurologica Scandinavica.

Multiple sclerosis and exposure to solvents, ionizing radiation and animals.

O. Axelson, S. Pålhagen, A. Landtblom, 1993, Scandinavian journal of work, environment & health.

A Comparison of Gray Matter Density in Restless Legs Syndrome Patients and Matched Controls Using Voxel‐Based Morphometry

Thomas E. Nichols, Brandon Whitcher, C. Halldin, 2010, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease

P. Svenningsson, K. Winge, S. Pålhagen, 2013, Neuroscience Letters.

The influence of preanalytical conditions on the DJ-1 concentration in human cerebrospinal fluid.

P. Svenningsson, N. Heegaard, K. Winge, 2014, Biomarkers in medicine.

Does l‐dopa treatment contribute to reduction in body weight in elderly patients with Parkinson's disease?

M. Unosson, S. Pålhagen, G. Toss, 2005, Acta neurologica Scandinavica.

Metoprolol and propranolol in migraine prophylaxis: a double‐blind multicentre study

F. Johansson, S. Pålhagen, S. Pålhagen, 1984, Acta neurologica Scandinavica.

Selegiline slows the progression of the symptoms of Parkinson disease

R. Palm, S. Pålhagen, E. Heinonen, 2006, Neurology.

Rufinamide: a double-blind, placebo-controlled proof of principle trial in patients with epilepsy

O. Henriksen, S. Pålhagen, R. Canger, 2001, Epilepsy Research.

Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients.

Christer Halldin, Mikael Svensson, Andrea Varrone, 2015, The Journal of clinical investigation.

EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

P. Svenningsson, J. Volkmann, H. Reichmann, 2015, Movement disorders : official journal of the Movement Disorder Society.

Is excessive daytime sleepiness a separate manifestation in Parkinson's disease?

J. Broman, S. Pålhagen, S. Fredrikson, 2015, Acta neurologica Scandinavica.

Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression

P. Svenningsson, S. Pålhagen, Hongshi Qi, 2010, Journal of Neurology.

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.

L. Seeberger, L. Raymond, R. Barker, 2013, JAMA neurology.

Workforce unavailability in Parkinson's disease

S. Pålhagen, P. Odin, P. Hagell, 2017, Acta neurologica Scandinavica.

HMPAO SPECT in Parkinson’s disease (PD) with major depression (MD) before and after antidepressant treatment

Göran Granerus, S. Pålhagen, Ann-Kathrine Granérus, 2009, Journal of Neurology.

Progress in Neurotherapeutics and Neuropsychopharmacology: Use of Selegiline as Monotherapy and in Combination with Levodopa in the Management of Parkinson's Disease: Perspectives from the MONOCOMB Study

S. Pålhagen, E. Heinonen, 2008 .

Factors of importance for weight loss in elderly patients with Parkinson's disease

M. Unosson, S. Pålhagen, G. Toss, 2004, Acta neurologica Scandinavica.

Selegiline delays the onset of disability in de novo parkinsonian patients

R. Palm, S. Pålhagen, E. Heinonen, 1998, Neurology.

A Swedish version of the 16‐item Parkinson fatigue scale (PFS‐16)

S. Pålhagen, P. Hagell, S. Pålhagen, 2012, Acta neurologica Scandinavica.

Depressive illness in Parkinson’s disease – indication of a more advanced and widespread neurodegenerative process?

S. Pålhagen, J. Wålinder, M. Carlsson, 2008, Acta neurologica Scandinavica.

NMDA receptor gene variations as modifiers in Huntington disease: a replication study

J. Schiefer, R. Barker, R. Reilmann, 2011, PLoS currents.

Effect of selegiline on mortality in patients with Parkinson's disease

H. Przuntek, C. Olanow, K. Sotaniemi, 1998, Neurology.

Associations Between Fluctuations in Daytime Sleepiness and Motor and Non‐Motor Symptoms in Parkinson's Disease

P. Svenningsson, J. Broman, S. Pålhagen, 2020, Movement disorders clinical practice.

A 10-Year Follow-Up of Excessive Daytime Sleepiness in Parkinson's Disease

J. Broman, S. Pålhagen, S. Fredrikson, 2019, Parkinson's disease.

Neuropeptide Y and Calcitonin Gene-Related Peptide in Cerebrospinal Fluid in Parkinson’s Disease with Comorbid Depression versus Patients with Major Depressive Disorder

P. Svenningsson, S. Pålhagen, A. Mathé, 2017, Front. Psychiatry.